“…Bicuspid valves degenerate more frequently and rapidly than trileaflet aortic valves, and recent clinical history data suggest that as many as 50% of patients with echocardiographic diagnoses of bicuspid aortic valve eventually require aortic valve replacement (AVR) (2,3). The incidence of ascending aortic dissection in patients with bicuspid aortic valves is estimated to be 8 times higher than that in the general population (2), but single-center studies focusing on the long-term risk for dissection after isolated AVR in patients with bicuspid aortic valves have yielded conflicting outcome data (4)(5)(6)(7)(8), so the indications for concomitant intervention on the thoracic aorta at the time of AVR are controversial (9). Histopathologic similarities between specimens of aneurysms from patients with bicuspid aortic valves and Marfan syndrome (10,11) have led to the extrapolation of treatment algorithms for management of the ascending aorta in bicuspid aortic valve disease from aggressive guidelines established for the management of Marfan syndrome (12,13), despite the lack of supporting comparative clinical outcome data (14,15).…”